Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 501–600 of 1,000
Lundberg, E., Kriström, B., Zouater, H., Deleskog, A., & Höybye, C. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0535-4 · Cited by 13
LEAP‐2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study
Vergani, E., Bruno, C., Gavotti, C., Aversa, L. S., Martire, M. S., Mancini, A., & Currò, D. (2021) · IUBMB Life · doi:10.1002/iub.2504 · Cited by 11
Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency
Kildemoes, R. J., Hollensen, C., Biller, B. M. K., Johannsson, G., Takahashi, Y., & Rasmussen, M. H. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1167 · Cited by 14
Bidlingmaier, M., Biller, B. M. K., Clemmons, D. R., Jørgensen, J. O. L., Nishioka, H., & Takahashi, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1040046 · Cited by 16
Self-citationvan Schaïk, J., Kormelink, E., Kabak, E. G., van Dalen, E. C., Meeteren, A. Y. N. S., de Vos‐Kerkhof, E., Bakker, B., Fiocco, M. F., Hoving, E. W., Tissing, W. J. E., et al. (2023) · Neuroendocrinology · doi:10.1159/000531226 · Cited by 15
Adult hypopituitarism: Are we missing or is it clinical lethargy?
Brar, K. S., Garg, M. K., & Suryanarayana, K. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83400 · Cited by 17
Berryman, D. E., Henry, B. E., Hjortebjerg, R., List, E. O., & Kopchick, J. J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1147950 · Cited by 14
Emerging treatment options for patients with Laron syndrome
Laron, Z. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.912581 · Cited by 11
Yang, H., Li, K., Liang, X., Gu, B., Wang, L., Gong, G., Feng, F., You, H., Hou, B., Gong, F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01134 · Cited by 12
“Besides metabolic disorders, osteoporosis, sarcopenia and decreased quality of life, impaired cognitive function is one of the important characteristics of AGHD (Molitch et al., 2011; Uzunova et al., 2015).”
BackgroundMethodPersonalized approach to growth hormone replacement in adults
van Bunderen, C. C., Glad, C. A. M., Johannsson, G., & Olsson, D. S. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000189 · Cited by 14
Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review
Martin, B. S. D. S., Ferreira, V. G., Bitencourt, M. R., Pereira, P. C. G., Carrilho, E., Assunção, N. A., & Carvalho, L. R. S. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000300 · Cited by 17
Enhancing the Trustworthiness of the Endocrine Society’s Clinical Practice Guidelines
McCartney, C. R., Corrigan, M. D., Drake, M. T., Fuleihan, G. E., Korytkowski, M. T., Lash, R. W., Lieb, D. C., McCall, A. L., Muniyappa, R., Piggott, T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac290 · Cited by 13
Biller, B. M. K., Höybye, C., Ferran, J.-M., Kelepouris, N., Nedjatian, N., Olsen, A. H., Weber, M. M., & Gordon, M. B. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad054 · Cited by 12
Growth Hormone Therapy in Childhood: Titration Versus Weight-Based Dosing?
Baron, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0900 · Cited by 12
Mortality and Reduced Growth Hormone Secretion
Stochholm, K., Christiansen, J. S., Laursen, T., & Gravholt, C. H. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110618 · Cited by 12
Growth hormone and changes in energy balance in growth hormone deficient adults
Deepak, D. S., Daousi, C., Boyland, E. J., Pinkney, J. H., Wilding, J. P. H., & MacFarlane, I. A. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01993.x · Cited by 13
Growth hormone replacement in adults: Real-world data from two large studies in US and Europe
Weber, M. M., Gordon, M. B., Höybye, C., Jørgensen, J. O. L., Puras, G., Popović-Brkić, V., Molitch, M. E., Ostrow, V., Holot, N., Pietropoli, A., et al. (2019) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2019.09.002 · Cited by 13
Self-citationRetrospective observational analysis of non-irradiated non-functioning pituitary adenomas
Karamouzis, I., Berardelli, R., Prencipe, N., Berton, A. M., Bona, C., Stura, G., Corsico, M., Gasco, V., Maccario, M., Ghigo, E., et al. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0361-0 · Cited by 12
What Endocrinologists Should Know About Growth Hormone Measurements
Bidlingmaier, M., & Strasburger, C. J. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.004 · Cited by 12
Ectopic lipid metabolism in anterior pituitary dysfunction
Baumgartner, C., Krššák, M., Vila, G., Krebs, M., & Wolf, P. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1075776 · Cited by 12
“Contrary to acromegalic fat distribution, GHD-patients inherit IR alongside an elevated visceral and ectopic fat mass in combination with a concomitantly reduced lean body mass (84).”
BackgroundHerodes, M., Le, N., Anderson, L. J., Migula, D., Miranda, G., Paulsen, L., & Garcia, J. M. (2023) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2023.101544 · Cited by 12
Accuracy of Glucagon Testing Across Transition in Young Adults With Childhood-Onset GH Deficiency
Fava, D., Guglielmi, D., Pepino, C., Angelelli, A., Casalini, E., Varotto, C., Panciroli, M., Tedesco, C., Camia, T., Naim, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae408 · Cited by 11
Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder
Makras, P., Erickson, D. Z., Davidge-Pitts, C. J., Diamond, E. L., Allen, C. E., McClain, K. L., Abeykoon, J. P., Go, R. S., Siwakoti, K., Sotoudeh, H., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae827 · Cited by 12
Vaňuga, P., Kužma, M., Stojkovičová, D., Smaha, J., Jackuliak, P., Killinger, Z., & Payer, J. (2021) · Physiological Research · doi:10.33549/physiolres.934775 · Cited by 14
Managing Estrogen Therapy in the Pituitary Patient
Shoung, N., & Ho, K. K. Y. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad051 · Cited by 11
GH replacement reduces increased lipid peroxidation in GH‐deficient adults
Karbownik‐Lewińska, M., Kokoszko, A., Lewandowski, K. C., Shalet, S. M., & Lewiñski, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03142.x · Cited by 11
An update on the diagnosis of growth hormone deficiency
Gabreanu, G. R. (2018) · Discoveries · doi:10.15190/d.2018.2 · Cited by 12
Hypophysitis related to immune checkpoint inhibitors: An intriguing adverse event with many faces
Deligiorgi, M. V., Liapi, C. A., & Trafalis, D. T. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1869211 · Cited by 13
Dynamic Tests in Pituitary Endocrinology: Pitfalls in Interpretation during Aging
Caputo, M., Mele, C., Ferrero, A., Leone, I., Daffara, T., Marzullo, P., Prodam, F., & Aimaretti, G. (2021) · Neuroendocrinology · doi:10.1159/000514434 · Cited by 12
Hypopituitarism in the elderly: two case-reports with heterogeneous presentation
Foppiani, L., Ruelle, A., Quilici, P., & Monte, P. D. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324902 · Cited by 11
Growth hormone deficiency in the transition period: body composition and gonad function.
Balercia, G., Giovannini, L., Paggi, F., Spaziani, M., Tahani, N., Boscaro, M., Lenzi, A., & Radicioni, A. F. (2011) · PubMed · doi:10.3275/7804 · Cited by 14
Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency.
Eskes, S. A., Tomasoa, N. B., Endert, E., Geskus, R. B., Fliers, E., & Wiersinga, W. M. (2009) · PubMed · Cited by 14
Evaluation of pituitary function
Cheer, K., & Trainer, P. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00010-1 · Cited by 12
Yuen, K. C. J., Heaney, A. P., & POPOVIC, V. M. (2016) · Endocrine · doi:10.1007/s12020-015-0840-2 · Cited by 12
Cuttler, L., Misra, M., & Koontz, M. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00022-6 · Cited by 12
Yang, H., Chen, M., Wang, Y., Jiang, L., Wang, L., Duan, L., Gong, F., Zhu, H., & Pan, H. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad129 · Cited by 11
Abe, I., Takeshita, K., Nagata, M., Fujita, Y., Ochi, K., Koga, M., Kudo, T., Shimada, H., Abe, M., Mukoubara, S., et al. (2023) · Medicine · doi:10.1097/md.0000000000034730 · Cited by 11
Leslie, J. B., Pergolizzi, J. V., Macario, A., Apfel, C. C., Clair, D., Richmond, C., Florio, F., & Auster, M. (2008) · Cited by 10
Efficacy and Safety of Stereotactic Radiotherapy in Cushing’s Disease: A Single Center Experience
Apaydın, T., Özkaya, H. M., Durmaz, S. M., Meral, R., & Kadıoğlu, P. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1217-7365 · Cited by 11
“Growth hormone (GH) insufficiency was defined as the presence of two or more pituitary hormone deficiencies and an IGF level than ≤ 84 ng/ml or a peak GH level below 3 μg/l during the ITT [24].”
BackgroundUpdate on vertebral fractures in pituitary diseases: from research to clinical practice
Carrone, F., Ariano, S. A., Piccini, S., Milani, D., Mirani, M., Balzarini, L., Lania, A. G., & Mazziotti, G. (2021) · HORMONES · doi:10.1007/s42000-021-00275-5 · Cited by 11
GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study
Gagliardi, I., Mungari, R., Gamberini, M. R., Fortini, M., Dassie, F., Putti, M. C., Maffei, P., Aliberti, L. M., Bondanelli, M., Zatelli, M. C., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01780-z · Cited by 10
“2 μg/l for those with a BMI > 30 kg/m2 [22, 24].”
BackgroundMethodCannavò, S., Cappa, M., Ferone, D., Isidori, A. M., Loche, S., Salerno, M., Maghnie, M., Delphi panel members (paediatric, A. E., Aimaretti, G., Ambrosio, M. R., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01880-w · Cited by 10
“1 According to the 2006 consensus [48], patients with genetic isolated GHD or MPHD do not need to be retested 83 91 Keeps agreement”
BackgroundGul, R., Hanif, M. U., Gul, F., Rehman, H. M., Saleem, M., Ahmad, M. S., & Mirza, M. U. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00612-y · Cited by 10
Jung, J., Jeong, Y., Xu, Y., Yi, J., Kim, M., Jeong, H., Shin, S. H., Yang, Y., Son, J. J., & Sung, C. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3562 · Cited by 10
Höybye, C., & Christiansen, J. S. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0059-8 · Cited by 11
Sinha, A., Hollingsworth, K. G., Ball, S. G., & Cheetham, T. D. (2013) · Clinical Endocrinology · doi:10.1111/cen.12252 · Cited by 10
Hypopituitarism patterns among adult males with prolactinomas
Peng, J., Qiu, M., Qi, S., Li, D., & Peng, Y.-P. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.01.029 · Cited by 10
Long-term effects of treatment of pituitary adenomas
Pereira, A. M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00024-1 · Cited by 11
Nutrition, obesity and hormones
Giammanco, M., Lantieri, L., Leto, G., Pescia, F., & Majo, D. D. (2018) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2018.7755 · Cited by 15
van Santen, S. S., Olsson, D. S., van den Heuvel‐Eibrink, M. M., Wijnen, M., Hammarstrand, C., Janssen, J. A. M. J. L., Johannsson, G., van der Lely, A. J., & Neggers, S. J. C. M. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz279 · Cited by 10
GH deficiency in cancer survivors in the transition age: diagnosis and therapy
Sbardella, E., Crocco, M., Feola, T., Papa, F., Puliani, G., Gianfrilli, D., Isidori, A. M., & Grossman, A. B. (2020) · Pituitary · doi:10.1007/s11102-020-01052-0 · Cited by 10
Growth Hormone Deficiency in Childhood Intracranial Germ Cell Tumor Survivors
Lone, D. W., Sadak, K. T., Miller, B. S., Sample, J. M., Hubbard, A. K., Wolter, C., Roesler, M. A., Nuño, M. M., & Poynter, J. N. (2022) · Journal of Endocrinology and Metabolism · doi:10.14740/jem807 · Cited by 10
Shea, H. C., & Levy, R. A. (2011) · Endocrine Practice · doi:10.4158/ep11168.ra · Cited by 11
Ishtiaq, O., Haq, M. U., Rizwan, A., Masood, M. Q., Mehar, S., & Jabbar, A. (2009) · PubMed · Cited by 10
Hypopituitarism 3 and 12 months after traumatic brain injury and subarachnoid haemorrhage
Jonasdottir, A. D., Sigurjonsson, P., Olafsson, I. H., Karason, S., Sigthorsson, G., & Sigurjonsdottir, H. A. (2018) · Brain Injury · doi:10.1080/02699052.2017.1418906 · Cited by 9
Postoperative growth hormone dynamics in clinically nonfunctioning pituitary adenoma
Kobayashi, N., Yamaguchi‐Okada, M., Horiguchi, K., Fukuhara, N., Nishioka, H., & Yamada, S. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0536 · Cited by 10
Mancini, A., Bruno, C., Vergani, E., Guidi, F., Angelini, F., Meucci, E., & Silvestrini, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236357 · Cited by 10
Beck‐Peccoz, P., Höybye, C., Murray, R. D., Şimşek, S., Zabransky, M., Zouater, H., & Stalla, G. K. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820943377 · Cited by 10
Marcu, M., Trivin, C., Souberbielle, J., & Brauner, R. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-7 · Cited by 10
Selective use of the insulin tolerance test to diagnose hypopituitarism
Sarlos, S., & Inder, W. J. (2013) · Internal Medicine Journal · doi:10.1111/imj.12011 · Cited by 9
Sundari, L. P. R., & Arsani, N. L. K. A. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2422 · Cited by 17
Acute Sleep Disruption Does Not Diminish Pulsatile Growth Hormone Secretion in Pubertal Children
Calvert, M. E., Molsberry, S. A., Kangarloo, T., Amin, M. R., Genty, V., Faghih, R. T., Klerman, E. B., & Shaw, N. D. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac146 · Cited by 10
Mandal, S., Mukhopadhyay, P., & Ghosh, S. K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac260 · Cited by 10
Bioletto, F., Prencipe, N., Berton, A. M., Bona, C., Parasiliti‐Caprino, M., Faletti, R., Ghigo, E., Grottoli, S., & Gasco, V. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.910575 · Cited by 11
Bolier, M., van der Lelij, A., Janssens, G. O. R. J., van den Heuvel‐Eibrink, M. M., & Neggers, S. J. C. M. M. (2023) · Endocrine Related Cancer · doi:10.1530/erc-23-0026 · Cited by 12
Sulu, C., Koca, O., Icli, T. B., Öz, A., Kargın, O. A., Durcan, E., Şahin, S., Arslan, S., Turan, Ş., Kadıoğlu, P., et al. (2023) · Neuroradiology · doi:10.1007/s00234-023-03156-3 · Cited by 11
“The diagnosis, treatment, and follow-up of CD and adrenal-dependent CS were based on internationally agreed guidelines [30-33].”
MethodYang, L., Li, C., Song, T., & Zhan, X. (2023) · The EPMA Journal · doi:10.1007/s13167-023-00329-1 · Cited by 10
Carosi, G., Cremaschi, A., Giavoli, C., Ferrante, E., & Mantovani, G. (2024) · Pituitary · doi:10.1007/s11102-024-01463-3 · Cited by 9
“Adult-onset growth hormone deficiency (GHD) is linked to changes in body composition such as obesity and sarcopenia, as well as a compromised metabolic profile, leading to increased risk of cardiovascular disease and mortality [79].”
A monocentric experience of growth hormone replacement therapy in adult patients
Abdi, L., Sahnoun-Fathallah, M., Morange, I., Albarel, F., Castinetti, F., Giorgi, R., & Brue, T. C. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.05.002 · Cited by 9
“[2] Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML.”
BackgroundComparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Vance, S. A., Zeidan, E., Henrich, V. C., & Sandros, M. G. (2016) · Journal of Visualized Experiments · doi:10.3791/53508 · Cited by 9
IGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction
Tirosh, A., Toledano, Y., Masri‐Iraqi, H., Eizenberg, Y., Tzvetov, G., Hirsch, D., Benbassat, C. A., Robenshtok, E., & Shimon, I. (2016) · Pituitary · doi:10.1007/s11102-016-0718-1 · Cited by 9
“[5] and the Endocrine Society suggests the upper half of normal range [1].”
BackgroundInfluentialGrowth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test
Tavares, A. B. W., Seixas-da-Silva, I. A., Silvestre, D. H., Pinheiro, M. F. C., Vaisman, M., & Conceição, F. L. (2017) · Endocrine · doi:10.1007/s12020-017-1275-8 · Cited by 9
Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy
Gasco, V., Caputo, M., Cambria, V., Beccuti, G., Parasiliti‐Caprino, M., Ghigo, E., Maccario, M., & Grottoli, S. (2018) · Endocrine · doi:10.1007/s12020-018-1787-x · Cited by 10
Castillo, A. R., de Souza, A. L., Alegre, S. M., Atala, Y. B., Zantut‐Wittmann, D. E., & Garmes, H. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00534 · Cited by 11
Prevalence of growth hormone deficiency in middle-age adults recovering from stroke
Kreber, L. A., Ashley, M. J., Masel, B. E., Singh, C. K., Randle, K. D., Johnson, C., Helvie, R. E., Ashley, M. J., & Griesbach, G. S. (2019) · Brain Injury · doi:10.1080/02699052.2019.1682195 · Cited by 9
Growth hormone deficiency in adults with Cushing's disease
Tritos, N. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101474 · Cited by 11
Markkanen, H. M., Pekkarinen, T., Välimäki, M. J., Alfthan, H. V., Hämäläinen, E. K., & Stenman, U. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.06.002 · Cited by 10
Radetti, G., Iorgi, N. D., Paganini, C., Gastaldi, R., Napoli, F., Lorini, R., & Maghnie, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02842.x · Cited by 11
Meyer, S., İpek, M. Ş., Keth, A., Minnemann, T., von Mach, M.-A., Weise, A., Ittner, J. R., Nawroth, P. P., Plöckinger, U., Stalla, G. K., et al. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.03.001 · Cited by 9
Local overexpression of GH and GH/IGF1 effects in the adult mouse hippocampus
Walser, M., Samà, M. T., Wickelgren, R., Åberg, M., Bohlooly‐Y, M., Olsson, B., Törnell, J., Isgaard, J., & Åberg, N. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0077 · Cited by 9
Hypothalamic hamartoma associated with central precocious puberty and growth hormone deficiency
Rousseau-Nepton, I., Kaduri, S., Garfield, N., & Krishnamoorthy, P. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0108 · Cited by 9
Sgrò, P., Sansone, M., Parisi, A., Sartório, A., Sansone, A., Romanelli, F., Lenzi, A., & Luigi, L. D. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0489-6 · Cited by 10
“However, rhGH dose should be titrated according to clinical response, side effects and IGF-I levels [9].”
Osteoporosis in Childhood and Adolescence
Ward, L. M., Mughal, Z., & Bachrach, L. K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00043-1 · Cited by 10
Pena-Bello, L., Seoane‐Pillado, T., Sangiao‐Alvarellos, S., Outeiriño-Blanco, E., Varela-Rodríguez, B. M., Juiz-Valiña, P., Cordido, M., & Cordido, F. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.06.004 · Cited by 11
Funktionsdiagnostik in der Endokrinologie
Auernhammer, C. J., & Reincke, M. (2017) · Der Internist · doi:10.1007/s00108-017-0360-7 · Cited by 11
Pituitary disease mortality: is it fiction?
Erfurth, E. M., Siesjö, P., & Björk‐Eriksson, T. (2013) · Pituitary · doi:10.1007/s11102-013-0469-1 · Cited by 9
Growth Hormone Deficiency: Diagnosis and Therapy in Children
Bozzola, M., & Meazza, C. (2016) · InTech eBooks · doi:10.5772/64803 · Cited by 9
Cheng, L., Zhu, H., Wang, J., Wu, S., Zhang, S., Wang, J., & Shu, K. (2023) · Cancers · doi:10.3390/cancers15020340 · Cited by 10
Pitfalls in the lab assessment of hypopituitarism
Schilbach, K., & Bidlingmaier, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09881-1 · Cited by 9
Liu, A., Zhang, Y., Tian, P., Meng, T., Chen, J., Zhang, D., Zheng, Y., & Su, G. (2024) · BMC Public Health · doi:10.1186/s12889-024-19659-4 · Cited by 10
Xia, J., Li, L., Ren, W., Zheng, X., Liu, C., Li, J., Chen, T., Li, X., Wang, L., & Hu, Y. (2015) · Europe PMC (PubMed Central) · Cited by 8
Sotos, J. F., Miller, K. E., Corsmeier, D. J., Tokar, N. J., Kelly, B., Nadella, V., Zhong, H., Wetzel, A. N., Adler, B. H., Yu, C. Y., et al. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0052-z · Cited by 10
Yang, H., Wang, L., Qiu, X., Yan, K., Gong, F., Zhu, H., & Pan, H. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0019 · Cited by 9
Loher, H., Jenni, S., Bucher, J., Krüsi, M., Kreis, R., Boesch, C., & Christ, E. (2018) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2018.08.001 · Cited by 8
Paul, R. G., McMahon, C. D., Elston, M. S., & Conaglen, J. V. (2018) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2018.12.001 · Cited by 8
Tam, C. S., Johnson, W. D., Rood, J. C., Heaton, A. L., & Greenway, F. L. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000893 · Cited by 9
Growth hormone deficiency and the transition from pediatric to adult care
Tavares, A. B. W., & Collett‐Solberg, P. F. (2021) · Jornal de Pediatria · doi:10.1016/j.jped.2021.02.007 · Cited by 12
“adult height achievement; (3) re-evaluation of somatrotropic axis; (4) management of rhGH”
BackgroundInfluentialApproach to the Patient: Management of Pituitary Hormone Replacement Through Transition
Cerbone, M., Katugampola, H., Simpson, H., & Dattani, M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac129 · Cited by 9
Gasco, V., Cuboni, D., Varaldo, E., Bioletto, F., Berton, A. M., Bona, C., Prencipe, N., Ghigo, E., Maccario, M., & Grottoli, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02081-9 · Cited by 8
“The proportion of patients with low GH response to provocative tests increases with the number of other pituitary hormone deficiencies and several studies involving panhypopituitary patients have shown that under certain circumstances GH stimulation tests may be unnecessary to diagnose GHD [2, 10, 11].”
BackgroundInfluentialSeguridad y efectividad del tratamiento con hormona de crecimiento: estudio GeNeSIS en España
Tomás, C. L., Irigoyen, M. O., Cepas, E. C., Salvi, L., & García-Pérez, L. E. (2015) · Anales de Pediatría · doi:10.1016/j.anpedi.2015.05.002 · Cited by 10
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.